Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis

The aim of the review was to evaluate patient and treatment characteristics for patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PSMA radioligand therapy (PRLT) associated with above-average outcome. The systematic review and meta-analysis followed recommendations b...

Descripción completa

Detalles Bibliográficos
Autores principales: von Eyben, Finn Edler, Bauman, Glenn, von Eyben, Rie, Rahbar, Kambiz, Soydal, Cigdem, Haug, Alexander R., Virgolini, Irene, Kulkarni, Harshad, Baum, Richard, Paganelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730994/
https://www.ncbi.nlm.nih.gov/pubmed/33260535
http://dx.doi.org/10.3390/ijms21239054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730994/
https://www.ncbi.nlm.nih.gov/pubmed/33260535
http://dx.doi.org/10.3390/ijms21239054

Ejemplares similares